Ionpath

📍 Menlo Park, United States🗓 Founded 2014👥 41 employees💰 Last funded Mar 2019
Biotechnology Research🌐 ionpath.com
Website LinkedIn
Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpath’s MIBI™ (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis. With MIBI technology and the expertise of world class pathology and data science teams, Ionpath provides actionable insights to translational and clinical researchers at leading pharma, biotech, and research organizations in immuno-oncology, immunology, neuroscience and infectious disease research.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2014
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2015–2019 · investors recorded per year
2015320192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ionpath?
Ionpath has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Ionpath last raise funding?
The most recent investment in Ionpath recorded on gritt.io was in March 2019.
When was Ionpath founded?
Ionpath was founded in 2014.
What industry is Ionpath in?
Ionpath operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ionpath based?
Ionpath is headquartered in Menlo Park, United States.